Status:
UNKNOWN
Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients
Lead Sponsor:
Alvimedica Medical Technologies France
Collaborating Sponsors:
EVAMED
Conditions:
Diabetes
Coronaropathy
Eligibility:
All Genders
18+ years
Brief Summary
The study is a 'real-world' study which evaluates the safety and performance of the coronary DES-CRE8 in diabetic patients. As routine care, each patient will be followed until 12 months after stent ...
Eligibility Criteria
Inclusion
- ≥18 years old,
- patient informed and agreed to participate,
- patient with one or more lesions treated with one or more coronary stent CRE8,
- patient with a diabete insulin dependent or non-insulin dependant.
Exclusion
- pregnant or breast-feading women,
- patient who refused to participate,
- patient with another lesion treated during the same intervention with a balloon alone or with another stent
Key Trial Info
Start Date :
April 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
1030 Patients enrolled
Trial Details
Trial ID
NCT03842813
Start Date
April 9 2019
End Date
July 1 2022
Last Update
May 10 2021
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique de l'Europe
Amiens, France, 80090
2
Centre Hospitalier Avignon
Avignon, France, 84902
3
Centre Hospitalier Beauvais
Beauvais, France, 60000
4
Clinique Convert
Bourg-en-Bresse, France, 01004